Association of Generic Imatinib Availability and Pricing With Trends in Tyrosine Kinase Inhibitor Use in Patients With Chronic Myelogenous Leukemia.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33001149.
- Also identified by DOI 10.1001/jamaoncol.2020.4660 and PMC identifier 7530814.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study identifies trends in tyrosine kinase inhibitor use in patients with chronic myelogenous leukemia and the association those treatment choices have with health care costs.
Medical subject headings
- Antineoplastic Agents
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive